vs

Side-by-side financial comparison of INSEEGO CORP. (INSG) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $48.4M, roughly 1.6× INSEEGO CORP.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 1.0%, a 6.4% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 0.6%). INSEEGO CORP. produced more free cash flow last quarter ($11.6M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 13.6%).

Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

INSG vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.6× larger
VMD
$76.2M
$48.4M
INSG
Growing faster (revenue YoY)
VMD
VMD
+24.9% gap
VMD
25.5%
0.6%
INSG
Higher net margin
VMD
VMD
6.4% more per $
VMD
7.4%
1.0%
INSG
More free cash flow
INSG
INSG
$1.9M more FCF
INSG
$11.6M
$9.7M
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
13.6%
INSG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INSG
INSG
VMD
VMD
Revenue
$48.4M
$76.2M
Net Profit
$469.0K
$5.6M
Gross Margin
42.2%
57.9%
Operating Margin
2.7%
11.0%
Net Margin
1.0%
7.4%
Revenue YoY
0.6%
25.5%
Net Profit YoY
182.9%
30.7%
EPS (diluted)
$-0.02
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSG
INSG
VMD
VMD
Q4 25
$48.4M
$76.2M
Q3 25
$45.9M
$71.9M
Q2 25
$40.2M
$63.1M
Q1 25
$31.7M
$59.1M
Q4 24
$48.1M
$60.7M
Q3 24
$54.0M
$58.0M
Q2 24
$51.6M
$55.0M
Q1 24
$37.5M
$50.6M
Net Profit
INSG
INSG
VMD
VMD
Q4 25
$469.0K
$5.6M
Q3 25
$1.4M
$3.5M
Q2 25
$507.0K
$3.2M
Q1 25
$-1.6M
$2.6M
Q4 24
$-566.0K
$4.3M
Q3 24
$9.0M
$3.9M
Q2 24
$624.0K
$1.5M
Q1 24
$-4.5M
$1.6M
Gross Margin
INSG
INSG
VMD
VMD
Q4 25
42.2%
57.9%
Q3 25
41.6%
57.5%
Q2 25
41.1%
58.3%
Q1 25
47.3%
56.3%
Q4 24
37.3%
59.5%
Q3 24
34.8%
59.3%
Q2 24
36.4%
59.8%
Q1 24
35.3%
58.9%
Operating Margin
INSG
INSG
VMD
VMD
Q4 25
2.7%
11.0%
Q3 25
4.7%
7.8%
Q2 25
3.2%
8.1%
Q1 25
-1.3%
6.5%
Q4 24
3.7%
10.6%
Q3 24
1.9%
9.7%
Q2 24
3.6%
6.6%
Q1 24
-7.9%
4.4%
Net Margin
INSG
INSG
VMD
VMD
Q4 25
1.0%
7.4%
Q3 25
3.1%
4.9%
Q2 25
1.3%
5.0%
Q1 25
-5.0%
4.4%
Q4 24
-1.2%
7.1%
Q3 24
16.6%
6.7%
Q2 24
1.2%
2.7%
Q1 24
-11.9%
3.2%
EPS (diluted)
INSG
INSG
VMD
VMD
Q4 25
$-0.02
$0.14
Q3 25
$0.03
$0.09
Q2 25
$-0.03
$0.08
Q1 25
$-0.16
$0.06
Q4 24
$0.62
$0.10
Q3 24
$-0.06
$0.10
Q2 24
$-0.02
$0.04
Q1 24
$-0.44
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSG
INSG
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$24.9M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-4.0M
$141.5M
Total Assets
$93.8M
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSG
INSG
VMD
VMD
Q4 25
$24.9M
$13.5M
Q3 25
$14.6M
$11.1M
Q2 25
$13.2M
$20.0M
Q1 25
$35.1M
$10.2M
Q4 24
$39.6M
$17.5M
Q3 24
$12.0M
$11.3M
Q2 24
$49.0M
$8.8M
Q1 24
$12.3M
$7.3M
Stockholders' Equity
INSG
INSG
VMD
VMD
Q4 25
$-4.0M
$141.5M
Q3 25
$-7.7M
$133.6M
Q2 25
$-10.5M
$139.7M
Q1 25
$-13.0M
$134.8M
Q4 24
$-12.9M
$131.4M
Q3 24
$-85.1M
$125.0M
Q2 24
$-101.8M
$119.4M
Q1 24
$-105.6M
$116.3M
Total Assets
INSG
INSG
VMD
VMD
Q4 25
$93.8M
$199.2M
Q3 25
$85.8M
$202.4M
Q2 25
$83.1M
$184.6M
Q1 25
$93.0M
$178.1M
Q4 24
$100.0M
$177.1M
Q3 24
$113.4M
$169.5M
Q2 24
$149.6M
$163.9M
Q1 24
$122.1M
$154.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSG
INSG
VMD
VMD
Operating Cash FlowLast quarter
$12.0M
$18.4M
Free Cash FlowOCF − Capex
$11.6M
$9.7M
FCF MarginFCF / Revenue
24.0%
12.7%
Capex IntensityCapex / Revenue
0.7%
11.5%
Cash ConversionOCF / Net Profit
25.50×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$6.5M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSG
INSG
VMD
VMD
Q4 25
$12.0M
$18.4M
Q3 25
$3.2M
$18.4M
Q2 25
$-4.5M
$12.3M
Q1 25
$-3.5M
$2.9M
Q4 24
$-14.2M
$15.0M
Q3 24
$14.8M
$12.7M
Q2 24
$27.6M
$10.2M
Q1 24
$5.2M
$1.2M
Free Cash Flow
INSG
INSG
VMD
VMD
Q4 25
$11.6M
$9.7M
Q3 25
$3.1M
$10.7M
Q2 25
$-4.7M
$4.1M
Q1 25
$-3.5M
$-12.6M
Q4 24
$-14.3M
$3.2M
Q3 24
$14.8M
$1.7M
Q2 24
$27.6M
$1.2M
Q1 24
$-4.8M
FCF Margin
INSG
INSG
VMD
VMD
Q4 25
24.0%
12.7%
Q3 25
6.7%
14.9%
Q2 25
-11.6%
6.5%
Q1 25
-11.0%
-21.4%
Q4 24
-29.7%
5.2%
Q3 24
27.4%
3.0%
Q2 24
53.5%
2.3%
Q1 24
-9.5%
Capex Intensity
INSG
INSG
VMD
VMD
Q4 25
0.7%
11.5%
Q3 25
0.2%
10.6%
Q2 25
0.5%
12.9%
Q1 25
0.1%
26.2%
Q4 24
0.1%
19.5%
Q3 24
0.0%
19.0%
Q2 24
0.0%
16.3%
Q1 24
0.0%
11.9%
Cash Conversion
INSG
INSG
VMD
VMD
Q4 25
25.50×
3.27×
Q3 25
2.22×
5.23×
Q2 25
-8.81×
3.88×
Q1 25
1.09×
Q4 24
3.47×
Q3 24
1.65×
3.29×
Q2 24
44.31×
6.94×
Q1 24
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons